Aerie Pharmaceuticals reported $747.1M in Market Capitalization this September of 2022, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Aerie Pharmaceuticals AERI:US $ 0.36B 0.08B
Alimera Sciences ALIM:US $ 0.04B 0B
Amarin AMRN:US 0.59B 0.71B
Bluebird Bio BLUE:US $ 0.3B 0.05B
Cara Therapeutics CARA:US $ 0.49B 0.16B
Coherus Biosciences CHRS:US $ 0.56B 0.44B
Endo International Ordinary Shares ENDP:US 0.11B 0.43B
Horizon Pharma HZNP:US 18.34B 5.81B
Insmed INSM:US $ 2.36B 0.43B
Merk MRK:US $ 230.55B 23.1B
Mirati Therapeutics MRTX:US $ 3.73B 0.84B
Novartis NOVN:VX 194.34B 3.46B
Ophthotech OPHT:US $ 1.12B 0.83B
Pacira Pharmaceuticals PCRX:US $ 2.65B 0.77B
Regeneron Pharmaceuticals REGN:US $ 64.93B 10.87B
Revance Therapeutics RVNC:US $ 1.01B 0.39B
Supernus Pharmaceuticals SUPN:US $ 1.54B 0.18B
Teva Pharmaceutical Industries TEVA:US 8.48B 1.81B
Valeant Pharmaceuticals VRX:CN C$ 3.89B 6.25B
Zoetis ZTS:US $ 80.9B 7.98B